Literature DB >> 23701932

Predictive factors for pacemaker implantation in patients receiving an implantable loop recorder for syncope remained unexplained after an extensive cardiac and neurological workup.

Pietro Palmisano1, Michele Accogli, Maria Zaccaria, Giovanni Luzzi, Frida Nacci, Matteo Anaclerio, Stefano Favale.   

Abstract

BACKGROUND: Several previous implantable loop recorder (ILR) studies have shown bradyarrhythmic events requiring a pacemaker implantation in a significant proportion of patients with unexplained syncope (US). The aim of this observational, two-centre, study was to identify the predictive factors for pacemaker implantation in a population of patients receiving an ILR for US with suspected arrhythmic aetiology.
METHODS: Fifty-six patients (mean age 68 years, 61% male) with a history of US and negative cardiac and neurological workup, who underwent ILR implantation, were enrolled. After the implantation, a follow-up visit was undertaken after symptomatic events or every 3 months in asymptomatic subjects. The end-point of the study was the detection of a bradyarrhythmia (with or without a syncopal recurrence) requiring pacemaker implantation.
RESULTS: After a median ILR observation of 22 months, a clinically significant bradyarrhythmia was detected in 11 patients (20%), of which 9 cases related to syncopal relapses. In the multivariable analysis, three independent predictive factors for pacemaker implantation were identified: an age >75 years (odd ratio [OR]: 29.9; p=0.035); a history of trauma secondary to syncope (OR: 26.8; p=0.039); and the detection of periods of asymptomatic bradycardia, not sufficient to explain the mechanism of syncope, during conventional ECG monitoring (through 24 h Holter or in hospital telemetry), performed before ILR implantation (OR: 24.7; p=0.045).
CONCLUSIONS: An advanced age, a history of trauma secondary to syncope, and the detection of periods of asymptomatic bradycardia during conventional ECG monitoring were independent predictive factors for bradyarrhythmias requiring pacemaker implantation in patients receiving an ILR for US.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arrhythmias; Atrioventricular block; Implantable loop recorder; Pacemaker; Sinus arrest; Unexplained syncope

Mesh:

Year:  2013        PMID: 23701932     DOI: 10.1016/j.ijcard.2013.04.179

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.

Authors:  A Shams; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Clinical characteristics associated with bradycardia and asystole in patients with syncope undergoing long-term electrocardiographic monitoring with implantable loop recorder.

Authors:  Peter Mitro; Miloš Šimurda; Ervin Müller
Journal:  Wien Klin Wochenschr       Date:  2017-04-27       Impact factor: 1.704

3.  Implantable loop recorders in patients with unexplained syncope: Clinical predictors of pacemaker implantation.

Authors:  Martin Huemer; Ann-Kristin Becker; Alexander Wutzler; Philipp Attanasio; Abdul S Parwani; Philipp Lacour; Leif-Hendrik Boldt; Burkert Pieske; Wilhelm Haverkamp; Florian Blaschke
Journal:  Cardiol J       Date:  2018-02-05       Impact factor: 2.737

4.  Risk factors and a 3-month risk score for predicting pacemaker implantation in patients with atrial fibrillations.

Authors:  Frederik Dalgaard; Jannik Langtved Pallisgaard; Tommi Bo Lindhardt; Gunnar Gislason; Paul Blanche; Christian Torp-Pedersen; Martin H Ruwald
Journal:  Open Heart       Date:  2020-03-24

5.  Clinical predictors for bradycardia and supraventricular tachycardia necessitating therapy in patients with unexplained syncope monitored by insertable cardiac monitor.

Authors:  Tatsuya Onuki; Makoto Shoji; Hiroto Sugiyama; Shuhei Arai; Kosuke Yoshikawa; Hiroshi Mase; Masaaki Kurata; Miwa Kikuchi; Daisuke Wakatsuki; Taku Asano; Hiroshi Suzuki; Kaoru Tanno; Youichi Kobayashi; Toshiro Shinke
Journal:  Clin Cardiol       Date:  2021-03-16       Impact factor: 2.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.